Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing

Nature Protocols

Volumn 9, Issue 8, 2014, Pages 1848-1859

  Pavía Jiménez, Andrea ^a,b,c,d   Tcheuyap, Vanina Toffessi ^a,b,c,d   Brugarolas, James ^a,b,c,d  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; SUNITINIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER TRANSPLANTATION; CLINICAL PROTOCOL; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG RESPONSE; DRUG SCREENING; EXPERIMENTAL DESIGN; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CAPSULE; KIDNEY CARCINOMA; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STUDY DESIGN; TUMOR XENOGRAFT; ANIMAL; CARCINOMA, RENAL CELL; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY NEOPLASMS; LABORATORY DIAGNOSIS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROCEDURES; SCID MOUSE; TISSUE CULTURE TECHNIQUE; XENOGRAFT; CANCER RESISTANCE; PARANEOPLASTIC SYNDROME; TUMOR ENGRAFTMENT; TUMOR MODEL;

ANIMALS; CARCINOMA, RENAL CELL; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; KIDNEY NEOPLASMS; MICE, INBRED NOD; MICE, SCID; SPECIMEN HANDLING; TISSUE CULTURE TECHNIQUES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84905014283     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2014.108     Document Type: Article

References (27)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30 (2013
2. Janowitz, T., Welsh, S.J., Zaki, K., Mulders, P. & Eisen, T. Adjuvant therapy in renal cell carcinoma-past, present, and future. Semin. Oncol. 40, 482-491 (2013
3. Ocana, A., Pandiella, A., Siu, L.L. & Tannock, I.F. Preclinical development of molecular-Targeted agents for cancer. Nat. Rev. Clin. Oncol. 8, 200-209 (2011
4. Nogawa, M. et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. Cancer Lett. 217, 243-253 (2005
5. Liu, J. et al. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol. Oncol. 31, 264-270 (2013
6. Ebos, J.M. et al. Accelerated metastasis after short-Term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232-239 (2009
7. Rubio-Viqueira, B. & Hidalgo, M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin. Pharmacol. Ther. 85, 217-221 (2009
8. Beroukhim, R. et al. Patterns of gene expression and copy-number alterations in von Hippel-Lindau disease-Associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 69, 4674-4681 (2009
9. Karam, J.A. et al. Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma. Eur. Urol. 59, 619-628 (2011
10. Morton, C.L. & Houghton, P.J. Establishment of human tumor xenografts in immunodeficient mice. Nat. Protoc. 2, 247-250 (2007
11. Grisanzio, C. et al. Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients. J. Pathol. 225, 212-221 (2011
12. Lawrence, M.G. et al. A preclinical xenograft model of prostate cancer using human tumors. Nat. Protoc. 8, 836-848 (2013
13. Kim, M.P. et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat. Protoc. 4, 1670-1680 (2009
14. Chen, K., Ahmed, S., Adeyi, O., Dick, J.E. & Ghanekar, A. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus. PLoS ONE 7, e39294 (2012
15. Garber, K. From human to mouse and back: 'tumorgraft' models surge in popularity. J. Natl. Cancer Inst. 101, 6-8 (2009
16. Monsma, D.J. et al. Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue. J. Transl. Med. 10, 125 (2012
17. Fu, X.Y., Besterman, J.M., Monosov, A. & Hoffman, R.M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA 88, 9345-9349 (1991
18. Garcia, P.L. et al. Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma. PLoS ONE 8, e78183 (2013
19. DeRose, Y.S. et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17, 1514-1520 (2011
20. Walters, D.M. et al. Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15, 143-155 (2013
21. Hoffman, R. Imageable clinically relevant mouse models of metastasis. in Metastasis Research Protocols (eds. Dwek, M., Schumacher, U., & Brooks, S.A.) Ch. 11, 141-170 (Springer, 2014
22. Lee, M., Muller, F., Aquilanti, E., Hu, B. & DePinho, R. Stereotactic orthotopic xenograft injections into the mouse brain. Protoc. Exchange doi: 10.1038/protex.2012.041 (2012
23. Sivanand, S. et al. A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci. Transl. Med. 4, 137ra175 (2012
24. Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751-759 (2012
25. Pena-Llopis, S. & Brugarolas, J. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications. Nat. Protoc. 8, 2240-2255 (2013
26. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New Engl. J. Med. 366, 883-892 (2012
27. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225-233 (2014